Chief Executive Officer of iTeos Therapeutics, Inc. (NASDAQ:ITOS), Detheux Michel, sells 29,000 shares worth $826,534
According to iTeos Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jun 16 06:48 PM, company Chief Executive Officer, Detheux Michel disclosed selling 29,000 shares at a cost of $28.50. At the time of this transaction (Jun 14), this trade was worth $826,534 in total. As of Jun 14, Detheux Michel now owns 148,937 shares in total worth about $3,896,191.92.
For the last few recent trades made by iTeos Therapeutics, Inc. (NASDAQ:ITOS) Chief Executive Officer, Detheux Michel, we have the following information: